Updated Jul 16, 2026
Burnett Patrick has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.15M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 222 | $21.05 | $5K |
| 2026-05-06 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 684 | $23.61 | $16K |
| 2026-03-04 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 181 | $25.91 | $5K |
| 2026-03-04 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 6.1K | $25.16 | $154K |
| 2026-03-04 | ARQT | Arcutis Biotherapeutics, Inc. | A — Grant or award | 30.0K | $0.00 | |
| 2026-03-04 | ARQT | Arcutis Biotherapeutics, Inc. | A — Grant or award | 16.8K | $0.00 | |
| 2026-02-05 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale [10b5-1] | 9.8K | $25.81 | $253K |
| 2026-02-05 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale [10b5-1] | 3.7K | $25.50 | $94K |
| 2025-08-19 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 2.4K | $15.57 | $38K |
| 2025-08-19 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 1.8K | $16.16 | $28K |
| 2025-08-08 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 3.8K | $14.03 | $54K |
| 2025-08-04 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 2.6K | $14.33 | $38K |
| 2025-07-10 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 5.8K | $15.07 | $87K |
| 2025-07-10 | ARQT | Arcutis Biotherapeutics, Inc. | M — Option exercise | 5.8K | $0.00 | |
| 2025-07-10 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 23.0K | $15.05 | $346K |
| 2025-07-10 | ARQT | Arcutis Biotherapeutics, Inc. | M — Option exercise | 23.0K | $0.00 | |
| 2024-12-31 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 1.7K | $14.00 | $24K |
| 2024-11-26 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 16.0K | $10.14 | $163K |
| 2024-11-26 | ARQT | Arcutis Biotherapeutics, Inc. | M — Option exercise | 16.0K | $0.00 | |
| 2024-11-18 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 100 | $10.03 | $1K |
Burnett Patrick is a corporate insider — currently tracked as See Remarks of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 18 open-market sales ($2.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Burnett Patrick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.